JLVZX
Price
$22.67
Change
+$0.30 (+1.34%)
Updated
Dec 3 closing price
Net Assets
5.63B
VVIAX
Price
$74.33
Change
+$0.66 (+0.90%)
Updated
Dec 3 closing price
Net Assets
207.95B
Interact to see
Advertisement

JLVZX vs VVIAX

Header iconJLVZX vs VVIAX Comparison
Open Charts JLVZX vs VVIAXBanner chart's image
JPMorgan Large Cap Value R2
Price$22.67
Change+$0.30 (+1.34%)
VolumeN/A
Net Assets5.63B
Vanguard Value Index Adm
Price$74.33
Change+$0.66 (+0.90%)
VolumeN/A
Net Assets207.95B
JLVZX vs VVIAX Comparison Chart in %
View a ticker or compare two or three
VS
JLVZX vs. VVIAX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLVZX is a Buy and VVIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 208B vs. JLVZX (5.63B). VVIAX pays higher dividends than JLVZX: VVIAX (2.04) vs JLVZX (0.66). JLVZX was incepted earlier than VVIAX: JLVZX (17 years) vs VVIAX (25 years). JLVZX (1.27) is less costly to investors than VVIAX (0.05). JLVZX is a more actively managed with annual turnover of: 185.00 vs. VVIAX (9.00). JLVZX has a lower initial minimum investment than VVIAX: JLVZX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 6.10 vs. JLVZX (-2.36). VVIAX return over 5 years is better than : 60.40 vs. JLVZX (39.94).
JLVZXVVIAXJLVZX / VVIAX
Total Expense Ratio1.190.052,380%
Annual Report Gross Expense Ratio1.270.052,540%
Fund Existence17 years25 years-
Gain YTD14.52612.640115%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.63B208B3%
Annual Yield % from dividends0.662.0432%
Returns for 1 year-2.366.10-39%
Returns for 3 years17.3930.8256%
Returns for 5 years39.9460.4066%
Returns for 10 years64.62128.9050%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALLO1.520.18
+13.43%
Allogene Therapeutics
BCAB0.830.05
+6.00%
BioAtla
AGIO27.490.51
+1.89%
Agios Pharmaceuticals
WTGUU10.30N/A
N/A
Wintergreen Acquisition Corp.
UGI37.64-0.49
-1.29%
UGI Corp